A docking score function for estimating ligand-protein interactions: application to acetylcholinesterase inhibition.

Acetylcholinesterase (AChE) inhibition is an important research topic because of its wide range of associated health implications. A receptor-specific scoring function was developed herein for predicting binding affinities for human AChE (huAChE) inhibitors. This method entails a statistically trained weighted sum of electrostatic and van der Waals (VDW) interactions between ligands and the receptor residues. Within the 53 ligand training set, a strong correlation was found (R2 = 0.89) between computed and experimental inhibition constants. Leave-one-out cross-validation indicated high predictive power (Q2 = 0.72), and analysis of a separate 16-compound test set also produced very good correlation with experiment (R2 = 0.69). Scoring function analysis has permitted identification and characterization of important ligand-receptor interactions, producing a list of those residues making the most important electrostatic and VDW contributions within the main active site, gorge area, acyl binding pocket, and periferal site. These analyses are consistent with X-ray crystallographic and site-directed mutagenesis studies.

[1]  J. Borak,et al.  Chemical warfare agents: II. Nerve agents. , 1992, Annals of emergency medicine.

[2]  S. Gray,et al.  Donepezil Use in Alzheimer Disease , 1998, The Annals of pharmacotherapy.

[3]  Gerhard Klebe,et al.  Predicting binding modes, binding affinities and ‘hot spots’ for protein-ligand complexes using a knowledge-based scoring function , 2000 .

[4]  P Willett,et al.  Development and validation of a genetic algorithm for flexible docking. , 1997, Journal of molecular biology.

[5]  Andres D. Ramirez,et al.  5,7‐Dihydro‐3‐(2‐(1‐(phenylmethyl)‐4‐piperidinyl)ethyl)‐6H‐pyrrolo(3,2‐ f)‐1,2‐benzisoxazol‐6‐one: A Potent and Centrally‐Selective Inhibitor of Acetylcholinesterase with an Improved Margin of Safety. , 1995 .

[6]  Satu M. Somani,et al.  Chemical warfare agents , 1992 .

[7]  A. Goldman,et al.  Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein , 1991, Science.

[8]  T. Marrs.  Organophosphate poisoning. , 1993, Pharmacology & therapeutics.

[9]  F. Vallette,et al.  Molecular and cellular biology of cholinesterases , 1993, Progress in Neurobiology.

[10]  Wolfgang Sippl,et al.  Structure-based 3D QSAR and design of novel acetylcholinesterase inhibitors , 2001, J. Comput. Aided Mol. Des..

[11]  N. Ariel,et al.  Structures of recombinant native and E202Q mutant human acetylcholinesterase complexed with the snake-venom toxin fasciculin-II. , 2000, Acta crystallographica. Section D, Biological crystallography.

[12]  Ting Wang,et al.  Comparative binding energy (COMBINE) analysis of OppA-peptide complexes to relate structure to binding thermodynamics. , 2002, Journal of medicinal chemistry.

[13]  G. V. Paolini,et al.  Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes , 1997, J. Comput. Aided Mol. Des..

[14]  J. Sussman,et al.  Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs. , 1999, Structure.

[15]  Thomas Lengauer,et al.  A fast flexible docking method using an incremental construction algorithm. , 1996, Journal of molecular biology.

[16]  T. Halgren.  MMFF VI. MMFF94s option for energy minimization studies , 1999, J. Comput. Chem..

[17]  Jirí Damborský,et al.  Comparative binding energy analysis of haloalkane dehalogenase substrates: Modelling of enzyme-substrate complexes by molecular docking and quantum mechanical calculations , 2003, J. Comput. Aided Mol. Des..

[18]  Thomas Hughes,et al.  Inhibitors Tethered Near the Acetylcholinesterase Active Site Serve as Molecular Rulers of the Peripheral and Acylation Sites* , 2003, Journal of Biological Chemistry.

[19]  S. Wold,et al.  Comparative molecular field analysis , 1991 .

[20]  Philippe Bernard,et al.  Automated docking of 82 N-benzylpiperidine derivatives to mouse acetylcholinesterase and comparative molecular field analysis with 'natural' alignment , 1999, J. Comput. Aided Mol. Des..

[21]  Zoran Radić,et al.  Structural insights into ligand interactions at the acetylcholinesterase peripheral anionic site , 2003, The EMBO journal.

[22]  B Velan,et al.  The Architecture of Human Acetylcholinesterase Active Center Probed by Interactions with Selected Organophosphate Inhibitors , 1996, The Journal of Biological Chemistry.

[23]  P Taylor,et al.  The cholinesterases: from genes to proteins. , 1994, Annual review of pharmacology and toxicology.

[24]  J M Blaney,et al.  A geometric approach to macromolecule-ligand interactions. , 1982, Journal of molecular biology.

[25]  J. Sussman,et al.  The X-ray structure of a transition state analog complex reveals the molecular origins of the catalytic power and substrate specificity of acetylcholinesterase. , 1996 .

[26]  F. J. Luque,et al.  Towards improved acetylcholinesterase inhibitors: a structural and computational approach. , 2001, Mini reviews in medicinal chemistry.

[27]  R. Cramer,et al.  Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. , 1988, Journal of the American Chemical Society.

[28]  Y. Li,et al.  Molecular cloning of mouse acetylcholinesterase: Tissue distribution of alternatively spliced mRNA species , 1990, Neuron.

[29]  Y. Martin,et al.  A general and fast scoring function for protein-ligand interactions: a simplified potential approach. , 1999, Journal of medicinal chemistry.

[30]  N. Ariel,et al.  Substrate inhibition of acetylcholinesterase: residues affecting signal transduction from the surface to the catalytic center. , 1992, The EMBO journal.

[31]  Klaus R Liedl,et al.  Molecular docking studies of natural cholinesterase-inhibiting steroidal alkaloids from Sarcococca saligna. , 2003, Journal of medicinal chemistry.

[32]  P. Cowley,et al.  Quaternary salts of E2020 analogues as acetylcholinesterase inhibitors for the reversal of neuromuscular block. , 2002, Bioorganic & medicinal chemistry letters.

[33]  Wolfgang Sippl,et al.  Development of biologically active compounds by combining 3D QSAR and structure-based design methods , 2002, J. Comput. Aided Mol. Des..

[34]  J. Blake,et al.  Novel benzisoxazole derivatives as potent and selective inhibitors of acetylcholinesterase. , 1994, Journal of medicinal chemistry.

[35]  J Andrew McCammon,et al.  Studying enzyme binding specificity in acetylcholinesterase using a combined molecular dynamics and multiple docking approach. , 2002, Journal of the American Chemical Society.

[36]  M. Crismon,et al.  Tacrine: First Drug Approved for Alzheimer's Disease , 1994, The Annals of pharmacotherapy.

[37]  A Tropsha,et al.  Structure-based alignment and comparative molecular field analysis of acetylcholinesterase inhibitors. , 1996, Journal of medicinal chemistry.

[38]  Marta Murcia,et al.  Virtual screening with flexible docking and COMBINE-based models. Application to a series of factor Xa inhibitors. , 2004, Journal of medicinal chemistry.